SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-23-011533
Filing Date
2023-06-28
Accepted
2023-06-28 17:25:29
Documents
13
Period of Report
2023-06-23
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K omer-20230623x8k.htm   iXBRL 8-K 84670
2 EX-10.1 omer-20230623xex10.htm EX-10 201780
  Complete submission text file 0001558370-23-011533.txt   435661

Data Files

Seq Description Document Type Size
3 EX-101.SCH omer-20230623.xsd EX-101.SCH 3354
4 EX-101.LAB omer-20230623_lab.xml EX-101.LAB 15361
5 EX-101.PRE omer-20230623_pre.xml EX-101.PRE 10392
7 EXTRACTED XBRL INSTANCE DOCUMENT omer-20230623x8k_htm.xml XML 4664
Mailing Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119
Business Address 201 ELLIOTT AVENUE WEST SEATTLE WA 98119 206-676-5000
OMEROS CORP (Filer) CIK: 0001285819 (see all company filings)

IRS No.: 911663741 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34475 | Film No.: 231053317
SIC: 2834 Pharmaceutical Preparations